Valuation: Astellas Pharma Inc.

Market Cap 4,315B 27.12B 23.24B 21.75B 19.88B 37.52B 2,597B 37.92B 257B 100B 1,304B 102B 99.64B P/E 2027 *
11.7x
P/E 2028 * 12.4x
Enterprise Value 4,273B 26.86B 23.02B 21.53B 19.69B 37.15B 2,572B 37.55B 255B 99.08B 1,291B 101B 98.67B EV / Sales 2027 *
1.85x
EV / Sales 2028 * 1.81x
Free-Float
98.88%
Yield 2027 *
3.34%
Yield 2028 * 3.44%
1 day-0.29%
1 week+3.85%
Current month+8.97%
1 month+8.57%
3 months+5.82%
6 months-5.23%
Current year+14.64%
1 week 2,291
Extreme 2291
2,418.5
1 month 2,125
Extreme 2125
2,418.5
Current year 2,041
Extreme 2041
2,717
1 year 1,557.5
Extreme 1557.5
2,717
3 years 1,243.5
Extreme 1243.5
2,717
5 years 1,243.5
Extreme 1243.5
2,717
10 years 1,243.5
Extreme 1243.5
2,717
Manager TitleAgeSince
Chief Executive Officer 63 2023-02-09
Director of Finance/CFO 54 2023-10-31
Compliance Officer - 2025-03-31
Director TitleAgeSince
Chairman 66 2023-02-09
Director/Board Member 63 2019-05-31
Director/Board Member 58 2023-05-31
Change 5-day change 1-year change 3-year change Capi.($)
-0.29%+3.85%+43.25%+10.07% 26.92B
-0.67%+5.39%+75.21%+127.54% 1,119B
+1.04%+4.07%+52.29%+65.39% 651B
-0.17%+5.67%+25.60%+80.40% 468B
-1.38%+4.02%+41.64%+42.38% 374B
-0.52%+2.72%+24.32%+41.06% 302B
-1.06%+4.76%+1.19%+12.65% 259B
+1.03%+5.83%+51.11%+72.96% 238B
-0.53%+2.34%-17.77%-53.66% 208B
+0.42%+5.63%+27.86%+92.24% 181B
Average -0.21%+4.46%+32.47%+49.10% 382.68B
Weighted average by Cap. -0.23%+4.92%+43.92%+72.55%

Financials

2027 *2028 *
Net sales 2,315B 14.56B 12.47B 11.67B 10.67B 20.13B 1,394B 20.35B 138B 53.69B 700B 54.65B 53.47B 2,137B 13.43B 11.51B 10.77B 9.84B 18.58B 1,286B 18.77B 127B 49.54B 646B 50.43B 49.33B
Net income 356B 2.24B 1.92B 1.79B 1.64B 3.09B 214B 3.13B 21.22B 8.25B 108B 8.4B 8.22B 333B 2.09B 1.79B 1.68B 1.53B 2.89B 200B 2.92B 19.83B 7.71B 101B 7.85B 7.68B
Net Debt -41.87B -263M -226M -211M -193M -364M -25.2B -368M -2.5B -971M -12.66B -988M -967M -439B -2.76B -2.37B -2.21B -2.02B -3.82B -264B -3.86B -26.18B -10.18B -133B -10.36B -10.14B
Logo Astellas Pharma Inc.
Astellas Pharma Inc is a Japan-based company mainly engaged in the research, development, manufacture and sales of pharmaceutical products. The Company mainly operates Pharmaceutical Products business segment. The main products include XTANDI, BETANIS, MIRABETRIC, BETMIGA and new products ZOSPATA, EVERENZO and ENHOLTUMAB VEDOTIN, among others.
Employees
14,099
Date Price Change Volume
26-08-24 ¥2,399.50 -0.29% 1,374,500
26-08-24 ¥2,406.50 +0.82% 4,258,200
26-08-21 ¥2,387.00 -1.28% 4,564,900
26-08-20 ¥2,418.00 +3.47% 7,092,700
26-08-19 ¥2,337.00 +1.15% 8,354,700
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
2,406.50JPY
Average target price
2,476.43JPY
Spread / Average Target
+2.91%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4503 Stock